Cellectis
CLLS
51 hedge funds and large institutions have $54.7M invested in Cellectis in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 15 closing their positions.
31% more call options, than puts
Call options by funds: $277K | Put options by funds: $211K
6% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 16
6.42% less ownership
Funds ownership: 33.4% → 26.98% (-6.4%)
11% less funds holding
Funds holding: 57 → 51 (-6)
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
56% less capital invested
Capital invested by funds: $124M → $54.7M (-$69M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
+$7.63M |
| 2 |
Jane Street
New York
|
+$2.08M |
| 3 |
Millennium Management
New York
|
+$1.54M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.31M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$775K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$23.9M |
| 2 |
NAMA
Nikko Asset Management Americas
New York
|
-$5.4M |
| 3 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$5.1M |
| 4 |
6CM
683 Capital Management
New York
|
-$2.86M |
| 5 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
-$2.82M |
CLLS Hedge Fund Activity: Q1 2022 in Review
51 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q1 2022, worth a combined $54.7M — down 56% from $124M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of CLLS and 9 opened new positions — a net loss of 6 holders — while 16 trimmed existing stakes and 15 added.
The largest buyer was Long Focus Capital Management, adding an estimated $7.63M. The largest seller was ARK Investment Management, exiting entirely with an estimated $23.9M sold.
- 51 institutional investors held Cellectis (CLLS) as of Q1 2022, down from 57 in Q4 2021.
- Funds reported $54.7M of Cellectis stock for Q1 2022, down 56% quarter-over-quarter.
- 9 funds opened new Cellectis positions in Q1 2022 and 15 closed out, a net change of -6 holders.
- The largest Cellectis buyer in Q1 2022 was Long Focus Capital Management, an estimated $7.63M added.
- The largest Cellectis seller in Q1 2022 was ARK Investment Management, an estimated $23.9M sold.
Based on aggregated 13F filings for Q1 2022.